Results 1 to 10 of about 101,346 (400)

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference

open access: yesGastroenterology, 2018
BACKGROUND & AIMS Over the last decade, clinical experiences and research studies raised concerns regarding use of proton pump inhibitors (PPIs) as part of the diagnostic strategy for eosinophilic esophagitis (EoE). We aimed to clarify the use of PPIs in
Evan Dellon   +2 more
exaly   +2 more sources

Ulcerative Esophagitis Caused by Cytomegalovirus During Infectious Mononucleosis in a Young and Immunocompetent Male Patient‐A Case Report [PDF]

open access: yesClinical Case Reports
Cytomegalovirus esophagitis mostly occurs in immunodeficient and severely acutely ill patients. Moreover, this diagnosis should be considered in otherwise healthy patients that experience reflux esophagitis symptom worsening under active CMV infectious ...
Duje Apostolski   +4 more
doaj   +2 more sources

Integrating AI with Advanced Hyperspectral Imaging for Enhanced Classification of Selected Gastrointestinal Diseases [PDF]

open access: yesBioengineering
Ulcerative colitis, polyps, esophagitis, and other gastrointestinal (GI) diseases significantly impact health, making early detection crucial for reducing mortality rates and improving patient outcomes.
Chu-Kuang Chou   +9 more
doaj   +2 more sources

EsoFLIP-assisted dilation for dysphagia in systemic sclerosis: Highlighting the role of multimodal esophageal evaluation [PDF]

open access: yesOpen Medicine
Scleroderma is an autoimmune disorder characterized by vasculopathy, progressive skin fibrosis, and dysfunction of internal organs. Esophageal involvement is seen in most scleroderma patients.
Chakraborty Subhankar, Yearsley Martha
doaj   +2 more sources

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Dupilumab, a fully human monoclonal antibody, blocks interleukin-4 and interleukin-13 signaling, which have key roles in eosinophilic esophagitis.
E. Dellon   +29 more
semanticscholar   +1 more source

VONOPRAZAN VERSUS LANSOPRAZOLE FOR HEALING AND MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS: A RANDOMIZED TRIAL.

open access: yesGastroenterology, 2022
BACKGROUND & AIMS For decades, proton pump inhibitors (PPIs) have been the mainstay of treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan provides more potent acid inhibition than PPIs but data on its efficacy for ...
L. Laine   +6 more
semanticscholar   +1 more source

Eosinophilic Esophagitis.

open access: yesNew England Journal of Medicine, 2021
Eosinophilic esophagitis (also known as EoE) is a disease characterized by the presence of a large number of a special type of white blood cell, the eosinophil, that can cause inflammation in the esophagus.
G. Furuta, D. Katzka
semanticscholar   +1 more source

Histomorphological and Immunophenotypic Features of Pill-Induced Esophagitis. [PDF]

open access: yesPLoS ONE, 2015
The aim of this study was to investigate histomorphological and immunophenotypic features in pill-induced esophagitis. We comparatively evaluated the histomorphological, immunophenotypic features of pill-induced esophagitis vs.
Ji Won Kim   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy